Asked Questions
Home / faq
Who is Pense Health for?
We serve biopharma sponsors, CROs, and research partners who are looking to improve trial speed, quality, and equity. Whether you’re running a complex protocol or planning your next study, Pense delivers real-time visibility and decision-making power.
What therapeutic areas do you support?
While our platform is designed to be therapeutic area-agnostic, we have deep expertise in autoimmune, immunology, and chronic specialty conditions—especially where diversity and recruitment challenges are most acute.
How quickly can we launch a study using Pense?
Implementation timelines vary, but we can typically begin delivering value within a few weeks, depending on trial readiness, site partners, and data availability.
How does Pense Health help identify and refer eligible patients for clinical trials?
Pense uses a combination of medical records and AI to match patients to trials more efficiently. Our platform analyzes longitudinal medical records to identify candidates who meet study criteria, reducing manual effort and increasing referral precision.
What is the role of e-HIPAA consent in the Pense platform?
Pense provides a secure, digital HIPAA authorization process that allows participants to consent to the sharing of their medical records for clinical trial consideration. This streamlined workflow ensures compliance while removing common barriers to record access.
How are medical records gathered and used?
Once consent is obtained, Pense aggregates and consolidates patient medical records from various sources. These records are securely delivered to the appropriate clinical trial site to support prescreening and accelerate the enrollment process.
Does Pense pre-qualify patients using AI?
Yes. Our platform uses AI to analyze patient data against protocol inclusion and exclusion criteria. This helps ensure only the most relevant candidates are referred to sites, reducing screen failure rates and saving valuable time.
Who is Pense Health for?
We serve biopharma sponsors, CROs, and research partners who are looking to improve trial speed, quality, and equity. Whether you’re running a complex protocol or planning your next study, Pense delivers real-time visibility and decision-making power.
What therapeutic areas do you support?
While our platform is designed to be therapeutic area-agnostic, we have deep expertise in autoimmune, immunology, and chronic specialty conditions—especially where diversity and recruitment challenges are most acute.
How quickly can we launch a study using Pense?
Implementation timelines vary, but we can typically begin delivering value within a few weeks, depending on trial readiness, site partners, and data availability.
How does Pense Health help identify and refer eligible patients for clinical trials?
Pense uses a combination of medical records and AI to match patients to trials more efficiently. Our platform analyzes longitudinal medical records to identify candidates who meet study criteria, reducing manual effort and increasing referral precision.
What is the role of e-HIPAA consent in the Pense platform?
Pense provides a secure, digital HIPAA authorization process that allows participants to consent to the sharing of their medical records for clinical trial consideration. This streamlined workflow ensures compliance while removing common barriers to record access.
How are medical records gathered and used?
Once consent is obtained, Pense aggregates and consolidates patient medical records from various sources. These records are securely delivered to the appropriate clinical trial site to support prescreening and accelerate the enrollment process.
Does Pense pre-qualify patients using AI?
Yes. Our platform uses AI to analyze patient data against protocol inclusion and exclusion criteria. This helps ensure only the most relevant candidates are referred to sites, reducing screen failure rates and saving valuable time.
Who is Pense Health for?
We serve biopharma sponsors, CROs, and research partners who are looking to improve trial speed, quality, and equity. Whether you’re running a complex protocol or planning your next study, Pense delivers real-time visibility and decision-making power.
What therapeutic areas do you support?
While our platform is designed to be therapeutic area-agnostic, we have deep expertise in autoimmune, immunology, and chronic specialty conditions—especially where diversity and recruitment challenges are most acute.
How quickly can we launch a study using Pense?
Implementation timelines vary, but we can typically begin delivering value within a few weeks, depending on trial readiness, site partners, and data availability.
How does Pense Health help identify and refer eligible patients for clinical trials?
Pense uses a combination of medical records and AI to match patients to trials more efficiently. Our platform analyzes longitudinal medical records to identify candidates who meet study criteria, reducing manual effort and increasing referral precision.
What is the role of e-HIPAA consent in the Pense platform?
Pense provides a secure, digital HIPAA authorization process that allows participants to consent to the sharing of their medical records for clinical trial consideration. This streamlined workflow ensures compliance while removing common barriers to record access.
How are medical records gathered and used?
Once consent is obtained, Pense aggregates and consolidates patient medical records from various sources. These records are securely delivered to the appropriate clinical trial site to support prescreening and accelerate the enrollment process.
Does Pense pre-qualify patients using AI?
Yes. Our platform uses AI to analyze patient data against protocol inclusion and exclusion criteria. This helps ensure only the most relevant candidates are referred to sites, reducing screen failure rates and saving valuable time.